Additionally, when we ranked liver cancer patients by MAPK10 expression in a descending order, we discovered that HCC patients with high MAPK10 expression had higher immune gene expression, higher scores of tumor infiltrating immune cells and stromal cells, but reduced transcriptomic signatures of hepatocellular carcinoma cancer cells compared to patients with low MAPK10 expression (Figure 3F). This evidence concerns the gene MAPK10 and hepatocellular carcinoma.